Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe L M J Verlinde

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Journal of Chemical Information and Modeling|September 30, 2008
Evaluation of different virtual screening programs for docking in a charged binding pocketWei Deng, Christophe L M J Verlinde
Parasitology|December 2, 2017
The calcium-dependent protein kinase 1 from Toxoplasma gondii as target for structure-based drug designEmily M Cardew, Christophe L M J Verlinde, Ehmke Pohl
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2006
Reengineering CCA-adding enzymes to function as (U,G)- or dCdCdA-adding enzymes or poly(C,A) and poly(U,G) polymerasesHyundae D Cho, Christophe L M J Verlinde, Alan M Weiner
Bioorganic & Medicinal Chemistry Letters|September 27, 2008
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIARob C Oslund, Nathan Cermak, Christophe L M J Verlinde, et al.
Journal of Medicinal Chemistry|August 19, 2005
The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas diseaseOliver Hucke, Michael H Gelb, Christophe L M J Verlinde, et al.
The Journal of Biological Chemistry|June 22, 2005
Methionine sulfoxide and proteolytic cleavage contribute to the inactivation of cathepsin G by hypochlorous acid: an oxidative mechanism for regulation of serine proteinases by myeloperoxidaseBaohai Shao, Abderrazzaq Belaaouaj, Christophe L M J Verlinde, et al.
Nucleosides, Nucleotides & Nucleic Acids|November 13, 2008
Design and synthesis of bis-carbamate analogs of cyclic bis-(3'-5')-diguanylic acid (c-di-GMP) and the acyclic dimer PGPGToni Kline, Stona R Jackson, Wei Deng, et al.
The Journal of Organic Chemistry|October 23, 2004
Large cyclic peptides as cores of multivalent ligands: application to inhibitors of receptor binding by cholera toxinZhongsheng Zhang, Jiyun Liu, Christophe L M J Verlinde, et al.
Chemical Biology & Drug Design|April 1, 2008
Multivalent drug design and inhibition of cholera toxin by specific and transient protein-ligand interactionsJiyun Liu, Darren Begley, Daniel D Mitchell, et al.
Journal of Medicinal Chemistry|August 22, 2003
Structure-based design of a macrocyclic inhibitor for peptide deformylaseXubo Hu, Kiet T Nguyen, Christophe L M J Verlinde, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Journal of Chemical Information and Modeling|September 30, 2008
Evaluation of different virtual screening programs for docking in a charged binding pocketWei Deng, Christophe L M J Verlinde
Parasitology|December 2, 2017
The calcium-dependent protein kinase 1 from Toxoplasma gondii as target for structure-based drug designEmily M Cardew, Christophe L M J Verlinde, Ehmke Pohl
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2006
Reengineering CCA-adding enzymes to function as (U,G)- or dCdCdA-adding enzymes or poly(C,A) and poly(U,G) polymerasesHyundae D Cho, Christophe L M J Verlinde, Alan M Weiner
Bioorganic & Medicinal Chemistry Letters|September 27, 2008
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIARob C Oslund, Nathan Cermak, Christophe L M J Verlinde, et al.
Journal of Medicinal Chemistry|August 19, 2005
The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas diseaseOliver Hucke, Michael H Gelb, Christophe L M J Verlinde, et al.
The Journal of Biological Chemistry|June 22, 2005
Methionine sulfoxide and proteolytic cleavage contribute to the inactivation of cathepsin G by hypochlorous acid: an oxidative mechanism for regulation of serine proteinases by myeloperoxidaseBaohai Shao, Abderrazzaq Belaaouaj, Christophe L M J Verlinde, et al.
Nucleosides, Nucleotides & Nucleic Acids|November 13, 2008
Design and synthesis of bis-carbamate analogs of cyclic bis-(3'-5')-diguanylic acid (c-di-GMP) and the acyclic dimer PGPGToni Kline, Stona R Jackson, Wei Deng, et al.
The Journal of Organic Chemistry|October 23, 2004
Large cyclic peptides as cores of multivalent ligands: application to inhibitors of receptor binding by cholera toxinZhongsheng Zhang, Jiyun Liu, Christophe L M J Verlinde, et al.
Chemical Biology & Drug Design|April 1, 2008
Multivalent drug design and inhibition of cholera toxin by specific and transient protein-ligand interactionsJiyun Liu, Darren Begley, Daniel D Mitchell, et al.
Journal of Medicinal Chemistry|August 22, 2003
Structure-based design of a macrocyclic inhibitor for peptide deformylaseXubo Hu, Kiet T Nguyen, Christophe L M J Verlinde, et al.
Pageof 9